HB 684 requires health insurance companies to notify members 60 days in advance if a provider (including primary care or behavioral health providers) is removed from their network, unless termination relates to fraud, abuse, or licensure issues. It mandates that members affected by such changes receive a 90-day special enrollment period to continue seeing those providers, along with clear contact information for filing complaints. Insurance companies must also notify the Maryland Insurance Commissioner about network changes at least 60 days before termination and update their access plans within 5 business days of the change. This bill directly affects health insurance members who lose provider access and requires insurers to follow specific transparency and transition procedures.
This bill requires Maryland hospitals to screen patients in emergency departments for pregnancy-related medical emergencies. If a patient has such a condition, hospitals must stabilize it through appropriate treatment - including pregnancy termination when medically necessary - before transferring them, and cannot transfer unstable patients without following federal emergency transfer rules. It prohibits hospitals from retaliating against staff who refuse transfers of unstable patients or report violations, and imposes civil penalties (up to $50,000) for noncompliance. The law applies to all Maryland hospitals and aims to ensure timely, stable care for pregnant patients in medical crises.
HB 625 shifts responsibility for collecting fees from research facilities to the Maryland Department of Agriculture, replacing the current system under the Department of Health. It requires facilities submitting USDA Form 7023 (for animal testing) to pay annual contributions based on animal count: $5,000 for ≤100 animals, $10,000 for 101-500, $55,000 for 501-5,000, and $75,000 for over 5,000. Funds collected will support the Human-Relevant Research Fund established under Maryland’s Economic Development Article. The bill repeals existing health code provisions and creates new agriculture code sections for this fee structure, effective October 2026.
SB 466 modifies Maryland's income tax credit for physicians mentoring medical students in underserved areas. It removes a requirement that students must be enrolled in Maryland medical schools and reduces the minimum hours per clinical rotation from 100 to 90. The bill directly affects licensed physicians serving as preceptors in areas designated as having health care workforce shortages by the state. This change aims to expand eligibility for the $1,000-per-student rotation tax credit (capped at $10,000 annually per physician), potentially increasing mentor availability in shortage regions. The credit remains limited to $100,000 total annually for all physicians.
HB 1367 establishes a Commission on Re-Imagining Health Care in Maryland to study and recommend changes for a new statewide healthcare system. The commission, composed of 20 appointed members including state officials, healthcare providers, insurers, county representatives, and community members, will examine how healthcare is delivered in other regions and address issues like provider shortages, cost balancing, and system integration. It will specifically study how to create a patient-centered system covering all health needs, eliminate access barriers, and ensure financial sustainability for all Maryland residents. The commission’s final recommendations, due by 2028, would guide potential future policy changes but do not enact any immediate healthcare reforms.
HB 1533 (the Crown and Care Act) bans 12 specific harmful ingredients - including certain phthalates, formaldehyde, mercury, and PFAS chemicals - from cosmetic products sold in Maryland. It directly affects cosmetic manufacturers, retailers, and salons by prohibiting the sale or distribution of products containing these ingredients, with limited exceptions for unavoidable trace amounts from manufacturing processes. The bill authorizes the Maryland Department of Health to investigate complaints, inspect businesses, and enforce penalties, while allowing consumers harmed by violations to seek civil damages and attorney fees. This law aims to protect public health by reducing exposure to chemicals linked to health risks like skin irritation and potential long-term harm.
SB 656 bans 12 specific harmful chemicals in cosmetics sold in Maryland, including formaldehyde, mercury, and certain PFAS chemicals. It creates civil liability for manufacturers or sellers who violate this ban, allowing consumers to sue for damages. The Maryland Department of Health gains authority to investigate complaints, inspect businesses, and collect product samples. The law exempts trace amounts of banned ingredients that occur unavoidably during manufacturing. The bill takes effect July 1, 2026.
SB 773 allows pharmacists in Maryland to order certain vaccinations (like flu, COVID-19, or emergency vaccines) for patients aged 3 and older without needing to administer the vaccine themselves. To qualify, pharmacists must complete 20 hours of approved training, hold current CPR certification, and complete 2 hours of continuing education on immunizations. The bill requires pharmacists to follow written vaccine-specific protocols, report all vaccinations to Maryland’s ImmuNet registry, and refer pediatric patients to primary care providers when appropriate. This policy directly affects pharmacists, patients seeking these vaccines, and healthcare coordination for immunizations. The changes take effect October 1, 2026.
HB 595 modifies Maryland's income tax credit for physicians mentoring medical students in underserved areas. It removes a requirement that students must be enrolled in a Maryland medical school or training program and reduces the required hours per preceptor rotation from 100 to 90 for community-based clinical training. Licensed physicians serving as preceptors in designated healthcare shortage areas may claim a $1,000 tax credit per qualifying student rotation, capped at $10,000 annually per physician and $100,000 statewide. The bill aims to expand access to physician mentorship by broadening eligibility for the credit, directly benefiting doctors and medical training programs in regions facing healthcare workforce shortages.
SB 412 establishes Maryland’s Community Forensic Aftercare Program within the Maryland Department of Health. The program monitors two groups: individuals committed to the health department due to being "not criminally responsible" (often called "not guilty by reason of insanity" cases), and people with mental illness or intellectual disability requiring community monitoring under specific legal circumstances. Key mechanisms include creating a community monitoring board to decide on conditional release and out-of-state travel, and requiring licensed social workers ("Program Monitors") to track compliance with court orders and make health recommendations. The bill amends Maryland’s Criminal Procedure and Health codes to implement this program, focusing on safety and structured oversight for these individuals.